PATH | GenomeWeb

PATH

The platform — called NINA for non-instrumented nucleic acid amplification — is designed to work with a wide range of isothermal amplification methods.

Researchers tested three methods - a bandage, an elastic sweatband, and a strip of cotton fabric - for securing tubes (whose position is noted with arrows) in the axilla.

Isothermal molecular method incubated in the armpit allows researchers to detect HIV-1 DNA in proof-of-concept study.

A public-private research team spearheaded by GE Global Research and the University of Washington is six months into a $9.6 million, 18-month grant from the Defense Advanced Research Projects Agency to develop an integrated, handheld molecular diagnostic platform for use at the p

Micronics (Sony) has been awarded US Patent No. 8,431,389, "Portable high-gain fluorescence detection system."
Frederick Battrell and Troy Daiber are named as inventors.

Scientists from Seattle's PATH institute, the Fred Hutchinson Cancer Research Center, and Alere subsidiary TwistDx have published a paper demonstrating the rapid detection of HIV-1 proviral DNA using assays based on TwistDx's recombinase polymerase amplification, an isothermal am

This article has been updated from a previous version to correct the names of an individual and research institution.

Scientists from PATH and the US Centers for Disease Control will collaborate under a three-year grant from the National Institutes of Health to further develop and test a non-instrumented DNA amplification kit for diagnosing diseases in resource-poor areas of the world, according

As part of ongoing research to create an "equipment-free" nucleic acid assay, PATH researchers showed in a recent study that electricity-free exothermic reactions can successfully incubate an isothermal nucleic acid assay with results equivalent to commercially available PCR instruments.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.